The ERINHA’s Research Portfolio is an evolving strategy built on the WHO Research and Development Blueprint with systematic updates to match with European and Global Research and Innovation and Public Health needs. The current prioritized agents are the following: Ebola, Marburg, Lassa, Crimean-Congo Hemorrhagic Fever, Nipah/Hendra, Unknown agents.

ERINHA’s research approach ranges from discovery to prevention on the field of highly pathogenic agents. The main fields are to provide diagnostic capabilities, increase the understanding of the diseases, develop new interventions and translate them to the market demands.
Read more: https://www.erinha.eu/research-strategy